FREDERICK, Md., July 28, 2020 /PRNewswire/ -- NetNoggin®, a premier market research agency that specializes in the pharmaceutical industry, has announced the release of its newest research report, NetNog: #genesis® Cystic Fibrosis V2.0 with updates due to TRIKAFTA.
NetNog: #genesis® Cystic Fibrosis V2.0 is a syndicated market research report that compares clinical literature and guidelines to patient and caregiver perspectives using netnographic methodologies. The original NetNog: #genesis® Cystic Fibrosis report was published in spring 2018. However, with the approval of TRIKAFTA in October 2019, the cystic fibrosis patient journey shifted. For the past nine months, NetNoggin® has been tracking this market disruption and reporting the impact TRIKAFTA is having on the cystic fibrosis market. This new report includes:
For pricing and/or to see a blinded version of NetNog: #genesis® Cystic Fibrosis V2.0, contact Megan Newcomer at [email protected].
NetNoggin®, a subsidiary of Conger Consulting, LLC, is a premier market research agency that specializes in pharmaceutical marketing. NetNoggin® takes unstructured social data and structures it using their technology and expert personnel (netnographers) who are trained in various disease areas, linguistics, storytelling, pharmaceutical marketing, and science to ensure the context and interpretation of the data is accurate. By leveraging 30+ years of experience, their proprietary process derives strategic consulting insights from big data to inform Foundational Marketing Tools (FMTs), strategies, and tactics. NetNoggin® has expertise in market research; commercial, market, and clinical development; and communications to provide reliable research, presentations, and workshops.
NetNoggin® Media Relations
If you would like more information on this topic, please contact Megan Newcomer.
E-mail: [email protected]
View original content to download multimedia:http://www.prnewswire.com/news-releases/netnoggin-announces-the-release-its-newest-research-report-netnog-genesis-cystic-fibrosis-v2-0-with-updates-due-to-trikafta-301101586.html